EAN News

Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination

Interim Results of a Phase 1–2a Trial of Ad26.COV2.S COVID-19 Vaccine

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

Early High-Titer Plasma Therapy to Prevent Severe COVID-19 in Older Adults

Convalescent Plasma Antibody Levels and the Risk of Death from COVID-19

Mask-wearing and control of SARS-CoV-2 transmission in the USA: a cross-sectional study

EAN Core Rainbow classification system: Algorithm used for classification of levels of evidence of research publications

Information on Moderna and Cominarty COVID-19 vaccines

European Academy of Neurology endorses the ALBA declaration on Equity and Inclusion

COVID-19 around the World: Clinician interviews on experience and impact of the virus (Saudi Arabia)

Greater decline of acute stroke admissions compared with acute coronary syndromes during COVID‐19 outbreak in Greece: Cerebro/Cardiovascular implications amidst a second wave surge

Neurology training and research in the COVID‐19 pandemic: A survey of the Resident and Research Fellow Section of the European Academy of Neurology

Perceived stress and social support in a large population of people with multiple sclerosis recruited online through COVID 19 pandemic.

Severe COVID-19-related encephalitis can respond to immunotherapy

Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome